MedTech Acquisition Co. (OTCMKTS:MTACU – Get Free Report) traded up 19.5% during trading on Friday . The stock traded as high as $11.35 and last traded at $11.35. 1,900 shares were traded during mid-day trading, an increase of 225% from the average session volume of 585 shares. The stock had previously closed at $9.50.
MedTech Acquisition Trading Up 19.5%
The firm’s 50 day simple moving average is $11.35 and its 200-day simple moving average is $11.35.
MedTech Acquisition Company Profile
MedTech Acquisition Corporation is a special purpose acquisition company formed in 2021 under the laws of Delaware and listed on the OTC Markets. The company’s primary objective is to complete a business combination with one or more businesses in the medical technology or life sciences sectors. By structuring as a blank check company, MedTech Acquisition seeks to leverage public market capital and strategic support to accelerate growth in a highly innovative industry.
MedTech Acquisition targets companies operating in areas such as diagnostic imaging, minimally invasive devices, regenerative medicine and digital health.
See Also
- Five stocks we like better than MedTech Acquisition
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- But this $2 Gold Stock Before May 20, 2026
- 3 Overlooked Deductions to Help Potentially Minimize Capital Gains Tax
Receive News & Ratings for MedTech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedTech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
